CN112094407A - Biguanide group covalent organic framework material and preparation method and application thereof - Google Patents
Biguanide group covalent organic framework material and preparation method and application thereof Download PDFInfo
- Publication number
- CN112094407A CN112094407A CN202011031835.5A CN202011031835A CN112094407A CN 112094407 A CN112094407 A CN 112094407A CN 202011031835 A CN202011031835 A CN 202011031835A CN 112094407 A CN112094407 A CN 112094407A
- Authority
- CN
- China
- Prior art keywords
- biguanide
- organic framework
- framework material
- covalent organic
- polylactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013310 covalent-organic framework Substances 0.000 title claims abstract description 64
- 239000000463 material Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 150000004283 biguanides Chemical group 0.000 title description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 54
- 239000004626 polylactic acid Substances 0.000 claims abstract description 54
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 52
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims abstract description 48
- 229940123208 Biguanide Drugs 0.000 claims abstract description 48
- 239000003054 catalyst Substances 0.000 claims abstract description 29
- 239000004310 lactic acid Substances 0.000 claims abstract description 26
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 26
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims abstract description 18
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000006068 polycondensation reaction Methods 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims description 54
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 37
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 238000006555 catalytic reaction Methods 0.000 claims description 14
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 14
- 238000003786 synthesis reaction Methods 0.000 claims description 14
- 239000000178 monomer Substances 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 11
- 241001024099 Olla Species 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- IXBPPZBJIFNGJJ-UHFFFAOYSA-N sodium;cyanoiminomethylideneazanide Chemical compound [Na+].N#C[N-]C#N IXBPPZBJIFNGJJ-UHFFFAOYSA-N 0.000 claims description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 150000004982 aromatic amines Chemical class 0.000 claims description 6
- WHSQATVVMVBGNS-UHFFFAOYSA-N 4-[4,6-bis(4-aminophenyl)-1,3,5-triazin-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C1=NC(C=2C=CC(N)=CC=2)=NC(C=2C=CC(N)=CC=2)=N1 WHSQATVVMVBGNS-UHFFFAOYSA-N 0.000 claims description 5
- RPHKINMPYFJSCF-UHFFFAOYSA-N benzene-1,3,5-triamine Chemical compound NC1=CC(N)=CC(N)=C1 RPHKINMPYFJSCF-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical group NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- QHQSCKLPDVSEBJ-UHFFFAOYSA-N 1,3,5-tri(4-aminophenyl)benzene Chemical compound C1=CC(N)=CC=C1C1=CC(C=2C=CC(N)=CC=2)=CC(C=2C=CC(N)=CC=2)=C1 QHQSCKLPDVSEBJ-UHFFFAOYSA-N 0.000 claims description 4
- 229920000877 Melamine resin Polymers 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 229910001882 dioxygen Inorganic materials 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 abstract description 10
- 229920000642 polymer Polymers 0.000 abstract description 7
- 238000006116 polymerization reaction Methods 0.000 abstract description 7
- 238000009826 distribution Methods 0.000 abstract description 4
- 239000013384 organic framework Substances 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 13
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 11
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 5
- 125000002619 bicyclic group Chemical group 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002638 heterogeneous catalyst Substances 0.000 description 4
- -1 porosity Substances 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 3
- GPRYKVSEZCQIHD-UHFFFAOYSA-N 1-(4-aminophenyl)ethanone Chemical compound CC(=O)C1=CC=C(N)C=C1 GPRYKVSEZCQIHD-UHFFFAOYSA-N 0.000 description 3
- YBAZINRZQSAIAY-UHFFFAOYSA-N 4-aminobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1 YBAZINRZQSAIAY-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 150000002357 guanidines Chemical class 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000002336 sorption--desorption measurement Methods 0.000 description 3
- 238000002411 thermogravimetry Methods 0.000 description 3
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KBYANRCVOIZOTD-UHFFFAOYSA-N acetic acid;2-amino-3,7-dihydropurin-6-one Chemical compound CC(O)=O.O=C1NC(N)=NC2=C1NC=N2 KBYANRCVOIZOTD-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012621 metal-organic framework Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000004729 solvothermal method Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- SYBFZFROLBNDDF-UHFFFAOYSA-N 4-[2,3-bis(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=CC(C=2C=CC(N)=CC=2)=C1C1=CC=C(N)C=C1 SYBFZFROLBNDDF-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000007172 homogeneous catalysis Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical group [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
- C08G63/82—Preparation processes characterised by the catalyst used
- C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
- C08G63/82—Preparation processes characterised by the catalyst used
- C08G63/87—Non-metals or inter-compounds thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
本发明公开了一种双胍基共价有机框架材料及其制备方法和应用,其双胍基共价有机框架材料具有二维的有机骨架,其特有的双胍结构可以直接作为乳酸直接缩聚合成聚乳酸以及丙交酯本体开环聚合成聚乳酸的催化剂。本发明通过将双胍引入至共价有机框架材料,从而达到对乳酸直接缩聚合成聚乳酸以及丙交酯本体开环聚合成聚乳酸的优异的催化效果,且聚合物聚合度可以根据需求受控合成,分子量分布指数PDI窄,催化剂与产物易于分离,且产物中无催化剂残留,合成的聚乳酸具有高度生物安全性;同时,这种由双胍构建而成的共价有机框架材料可以重复利用,大大降低了应用成本,可广泛推广应用。
The invention discloses a biguanide-based covalent organic framework material and a preparation method and application thereof. The biguanide-based covalent organic framework material has a two-dimensional organic framework, and its unique biguanide structure can be directly used as lactic acid to be directly polycondensed into polylactic acid and Catalyst for the bulk ring-opening polymerization of lactide into polylactic acid. By introducing biguanide into the covalent organic framework material, the present invention achieves excellent catalytic effect on the direct polycondensation of lactic acid into polylactic acid and the bulk ring-opening polymerization of lactide into polylactic acid, and the polymerization degree of the polymer can be controlled and synthesized according to requirements , the molecular weight distribution index PDI is narrow, the catalyst and the product are easy to separate, and there is no catalyst residue in the product, and the synthesized polylactic acid has high biosafety; at the same time, this covalent organic framework material constructed from biguanide can be reused, greatly The application cost is reduced, and the application can be widely promoted.
Description
技术领域technical field
本发明涉及一种双胍基共价有机框架材料及其制备方法和应用,属于胍类非均相催化剂技术领域。The invention relates to a biguanide-based covalent organic framework material, a preparation method and application thereof, and belongs to the technical field of guanidine heterogeneous catalysts.
背景技术Background technique
随着国内外生物医药领域的迅速发展,对具有优良的生物相容性与安全性的医药可降解材料的需求急剧增加,尤其是在能够应用于药物载体、组织修复材料等方面。聚乳酸由于较好的生物相容性与可降解性引起了广泛的关注,其在生物医药领域具有许多重要的应用。此前,聚乳酸的商品化生产主要采用辛酸亚锡开环聚合方法合成,但是聚合反应后无法完全地将含锡催化剂从聚合物中剔除。因此,开发不含锡、无毒、易于分离的催化剂显得尤为必要。With the rapid development of the field of biomedicine at home and abroad, the demand for medical degradable materials with excellent biocompatibility and safety has increased dramatically, especially in drug carriers and tissue repair materials. Polylactic acid has attracted extensive attention due to its good biocompatibility and degradability, and it has many important applications in the field of biomedicine. Previously, the commercial production of polylactic acid was mainly synthesized by the stannous octoate ring-opening polymerization method, but the tin-containing catalyst could not be completely removed from the polymer after the polymerization reaction. Therefore, it is particularly necessary to develop tin-free, non-toxic and easy-to-separate catalysts.
共价有机框架材料(Covalent Organic Frameworks,COFs)是由有机结构单元通过共价键连接的具有周期性结构的多孔化合物。与通过不可逆缩合连接的共价聚合物完全不同,COFs通过可逆反应显示出高度有序的晶体结构。与传统的晶体多孔固体(如沸石和金属有机骨架(MOFs))相比,COFs具有精确可预先设计的结构和量身定制的功能,可以实现针对功能的结构和化学控制。可以根据需要设计出不同组成、孔隙率、孔隙大小等来达到特定的用途。Covalent Organic Frameworks (COFs) are porous compounds with periodic structures linked by organic building blocks through covalent bonds. Completely different from covalent polymers linked by irreversible condensation, COFs display highly ordered crystal structures through reversible reactions. Compared with traditional crystalline porous solids, such as zeolites and metal-organic frameworks (MOFs), COFs have precise pre-engineered structures and tailored functions that enable function-specific structural and chemical control. Different compositions, porosity, pore sizes, etc. can be designed as required to achieve specific uses.
通常,COFs的合成方法包括溶剂热法、离子热法、微波辐射法和机械研磨法等。最常见的COFs制备方法是溶剂热法,即将反应单体、溶剂及催化剂加入体系中,经冻抽循环操作除氧后进行反应,在密闭反应体系中,通过控制溶剂种类、溶剂比例或反应压力,使其得在相对缓慢的过程中生成热力学稳定产物。传统的均相催化存在诸多不足,如反应产物与催化剂分离困难、催化剂难重复使用而造成极大浪费等,而使用COFs催化剂可有效解决上述难题。由于COFs的结构较为稳定且不溶于溶剂,因此其可以作为一个小空间的纳米反应器。在反应结束后,可以很容易地从反应混合物中分离出来,并且可以反复使用。Generally, the synthesis methods of COFs include solvothermal method, ionothermal method, microwave irradiation method and mechanical grinding method. The most common preparation method of COFs is the solvothermal method, that is, the reaction monomer, solvent and catalyst are added to the system, and the reaction is carried out after deoxygenation through a freeze-pump cycle operation. In a closed reaction system, by controlling the type of solvent, solvent ratio or reaction pressure. , making it thermodynamically stable products in a relatively slow process. There are many shortcomings in traditional homogeneous catalysis, such as the difficulty in separating the reaction product from the catalyst, and the difficulty in reusing the catalyst, resulting in great waste. The use of COFs catalyst can effectively solve the above problems. Since COFs are structurally stable and insoluble in solvents, they can be used as a small-space nanoreactor. After the reaction, it can be easily separated from the reaction mixture and can be used repeatedly.
胍是一种含氮的有机化合物,是一种有机强碱,其碱性与无机强碱相当,碱性与氢氧化钠相近,结构多样的胍类催化剂(双环型、单环型和无环型)的出现,使许多基本的有机转化得以高效地实现。但是由于胍类化合物的极性较大,在分离和纯化上较为困难,而且在合成方法上也有较多的限制。因此,将胍类化合物引入共价有机框架材料中来作为非均相催化剂,可以通过简单的回收加以利用并大大降低纯化成本以及生产成本。在双胍的改性上,此前有报道将其引入功能性胍离子液体,将二甲双胍固载在SiO2上以及引入到氨基功能化的介孔分子筛上等,但是总体的催化回收效率并不高。此外,胍也被应用到合成聚乳酸的研究中,如中国专利公开号CN 102875779 B的发明报道了双环胍催化乳酸缩聚合成医用生物降解性聚乳酸的工艺方法,又如中国专利公开号CN 104892916 B的发明报道了有机胍-无毒醇催化丙交酯活性开环聚合受控合成聚乳酸的工艺,但这些工艺依然未理想地提升催化效率以及回收再利用率。因此,结合共价有机框架材料的优点合成新型的胍类化合物的非均相催化剂,并达到良好的回收再利用的催化活性,依然具有很大的研究利用价值。Guanidine is a nitrogen-containing organic compound and an organic strong base. Its basicity is comparable to that of inorganic strong bases, and its basicity is similar to that of sodium hydroxide. Guanidine catalysts with various structures (bicyclic, monocyclic and acyclic) The emergence of the type) has enabled many basic organic transformations to be efficiently realized. However, due to the high polarity of guanidine compounds, it is difficult to separate and purify them, and there are also many limitations in the synthesis method. Therefore, the introduction of guanidine compounds into covalent organic framework materials as heterogeneous catalysts can be utilized through simple recycling and greatly reduce purification costs and production costs. In the modification of biguanide, it has been reported that it was introduced into functional guanidine ionic liquids, and metformin was immobilized on SiO2 and introduced into amino-functionalized mesoporous molecular sieves, etc., but the overall catalytic recovery efficiency was not high. In addition, guanidine is also applied in the research of synthesizing polylactic acid. For example, the invention of Chinese Patent Publication No. CN 102875779 B reports the process method of bicyclic guanidine catalyzed polycondensation of lactic acid into medical biodegradable polylactic acid, and Chinese Patent Publication No. CN 104892916 The invention of B reports a process for the controlled synthesis of polylactic acid by organic guanidine-non-toxic alcohol catalyzed active ring-opening polymerization of lactide, but these processes still do not ideally improve the catalytic efficiency and recycling rate. Therefore, combining the advantages of covalent organic framework materials to synthesize new heterogeneous catalysts of guanidine compounds and achieve good catalytic activity for recycling and reuse still has great research and utilization value.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于解决现有的胍类催化剂因胍类化合物合成困难、分离纯化上较为复杂而导致其在催化乳酸直接缩聚合成聚乳酸以及丙交酯本体开环聚合成聚乳酸的应用上的限制的问题。本发明通过将双胍引入至共价有机框架材料,从而达到对乳酸直接缩聚合成聚乳酸以及丙交酯本体开环聚合成聚乳酸的优异的催化效果,且聚合物聚合度可以根据需求受控合成,分子量分布指数PDI窄,催化剂与产物易于分离,且产物中无催化剂残留,合成的聚乳酸具有高度生物安全性;同时,这种由双胍构建而成的共价有机框架材料可以重复利用,大大降低了应用成本。The object of the present invention is to solve the problem of the existing guanidine catalysts in the application of catalyzing the direct polycondensation of lactic acid into polylactic acid and the ring-opening polymerization of lactide into polylactic acid due to the difficulty of guanidine compound synthesis and the complexity of separation and purification. limitation issue. By introducing biguanide into the covalent organic framework material, the present invention achieves excellent catalytic effect on the direct polycondensation of lactic acid into polylactic acid and the bulk ring-opening polymerization of lactide into polylactic acid, and the degree of polymerization of the polymer can be controlled according to requirements. , the molecular weight distribution index PDI is narrow, the catalyst and the product are easy to separate, and there is no catalyst residue in the product, the synthesized polylactic acid has high biosafety; at the same time, this covalent organic framework material constructed from biguanide can be reused, greatly Reduced application costs.
为实现上述发明目的,本发明采用如下技术方案:For realizing the above-mentioned purpose of the invention, the present invention adopts following technical scheme:
本发明的第一个方面提供了一种双胍基共价有机框架材料,所述的双胍基共价有机框架材料简称为COF-JNU,其特征结构如式1所示:A first aspect of the present invention provides a biguanide-based covalent organic framework material. The biguanide-based covalent organic framework material is abbreviated as COF-JNU, and its characteristic structure is shown in formula 1:
式1中,“L1”为结构;“L2”为 结构中的一种。In
本发明的第二个方面提供了一种双胍基共价有机框架材料COF-JNU的制备方法,包括如下步骤:将芳香胺和1,4-苯二氰基胍或者二氰胺钠以摩尔比2:3,在水或有机溶剂中,以盐酸为催化剂,在氮气保护下90~100℃反应24~48h,反应结束后经离心、洗涤、干燥即得所述的双胍基共价有机框架材料COF-JNU。A second aspect of the present invention provides a method for preparing a biguanide-based covalent organic framework material COF-JNU, comprising the steps of: mixing aromatic amine and 1,4-benzenedicyanoguanidine or sodium dicyanamide in a molar ratio 2:3, in water or an organic solvent, using hydrochloric acid as a catalyst, under nitrogen protection at 90 to 100 ° C for 24 to 48 hours, and after the reaction is completed, centrifugation, washing and drying are performed to obtain the biguanide-based covalent organic framework material. COF-JNU.
进一步地,所述的芳香胺为三聚氰胺、1,3,5-三氨基苯、2,4,6-三(4-氨基苯基)-1,3,5-三嗪或1,3,5-三(4-氨基苯基)苯中的一种。Further, the aromatic amine is melamine, 1,3,5-triaminobenzene, 2,4,6-tris(4-aminophenyl)-1,3,5-triazine or 1,3,5 - A kind of tris(4-aminophenyl)benzene.
进一步地,所述的有机溶剂为二甲基亚砜、N,N-二甲基甲酰胺、二氧六环中的一种或两种以上混合使用。Further, the organic solvent is one or more of dimethyl sulfoxide, N,N-dimethylformamide and dioxane used in combination.
进一步地,所述的盐酸的添加量为芳香胺的2-3倍当量。Further, the added amount of the hydrochloric acid is 2-3 times the equivalent of the aromatic amine.
本发明的第三个方面提供了一种双胍基共价有机框架材料COF-JNU在乳酸直接缩聚合成聚乳酸中的应用,所述的双胍基共价有机框架材料COF-JNU分两步加入反应体系进行催化反应,其催化反应方程式如下式2所示:The third aspect of the present invention provides the application of a biguanide-based covalent organic framework material COF-JNU in the direct polycondensation of lactic acid into polylactic acid. The biguanide-based covalent organic framework material COF-JNU is added in two steps to react The system carries out a catalytic reaction, and its catalytic reaction equation is shown in the following formula 2:
其中,第一步反应为寡聚乳酸OLLA的合成,即将预定量的L-乳酸和COF-JNU(相对于L-乳酸质量为0.5%),在氮气保护下置于30torr的密封反应釜,135℃下反应2~3h,得到寡聚乳酸OLLA的粘稠液体混合物;第二步反应为聚乳酸PLLA的合成,即将第一步制得的寡聚乳酸OLLA的粘稠液体混合物继续加热至175℃,同时将反应釜中压力降至10torr,反应0.5~4h,反应结束后冷却至室温,将反应液溶解于丙酮中,过滤回收催化剂COF-JNU,再将滤液倒入水中,静置后离心分离沉淀物,室温真空干燥可得白色固体,即为聚乳酸PLLA。采用本发明的双胍基共价有机框架材料COF-JNU在对乳酸直接缩聚合成聚乳酸的催化反应的产率为94%以上,Mn的范围为1×104~4.5×104,PDI为1.10~1.30。Wherein, the first step reaction is the synthesis of oligomeric lactic acid OLLA, that is, a predetermined amount of L-lactic acid and COF-JNU (relative to the quality of L-lactic acid is 0.5%), placed in a sealed reactor of 30torr under nitrogen protection, 135 The viscous liquid mixture of oligomeric lactic acid OLLA is obtained by reacting at ℃ for 2 to 3 hours; the second step is the synthesis of polylactic acid PLLA, that is, the viscous liquid mixture of oligomeric lactic acid OLLA obtained in the first step is continuously heated to 175 ℃ , at the same time, the pressure in the reactor was reduced to 10torr, and the reaction was carried out for 0.5 to 4 hours. After the reaction was completed, it was cooled to room temperature. The reaction solution was dissolved in acetone, and the catalyst COF-JNU was recovered by filtration. The filtrate was poured into water, and centrifuged after standing. The precipitate was dried under vacuum at room temperature to obtain a white solid, which was polylactic acid PLLA. Using the biguanide-based covalent organic framework material COF-JNU of the present invention, the yield rate of the catalytic reaction for the direct polycondensation of lactic acid into polylactic acid is over 94%, the Mn is in the range of 1×10 4 to 4.5×10 4 , and the PDI is 1.10 ~1.30.
本发明的第四个方面提供了一种双胍基共价有机框架材料COF-JNU在丙交酯本体开环聚合成聚乳酸中的应用,所述的双胍基共价有机框架材料COF-JNU直接加入丙交酯本体开环聚合成聚乳酸反应体系进行催化反应,其催化反应方程式如下式3所示:The fourth aspect of the present invention provides the application of a biguanide-based covalent organic framework material COF-JNU in the bulk ring-opening polymerization of lactide to form polylactic acid. The biguanide-based covalent organic framework material COF-JNU directly Add lactide bulk ring-opening polymerization into polylactic acid reaction system and carry out catalytic reaction, and its catalytic reaction equation is shown in the following formula 3:
具体步骤为:将单体L-丙交酯与COF-JNU(相对于L-丙交酯质量为0.5%),氮气保护下置于反应釜中,130℃下反应0.5~4h,反应结束后冷却至室温,将反应液溶解于丙酮中,过滤回收催化剂COF-JNU,再将滤液倒入水中,静置后离心分离沉淀物,室温真空干燥可得白色固体,即为聚乳酸PLLA。采用本发明的双胍基共价有机框架材料COF-JNU在对丙交酯本体开环聚合成聚乳酸进行催化反应的产率为95%以上,Mn的范围为1×104~5×104,PDI为1.10~1.30。The specific steps are as follows: the monomer L-lactide and COF-JNU (relative to the mass of L-lactide are 0.5%), placed in a reaction kettle under nitrogen protection, and reacted at 130 ° C for 0.5 to 4 hours. After cooling to room temperature, the reaction solution was dissolved in acetone, and the catalyst COF-JNU was recovered by filtration. The filtrate was poured into water, and the precipitate was separated by centrifugation after standing, and vacuum-dried at room temperature to obtain a white solid, which was polylactic acid PLLA. Using the biguanide-based covalent organic framework material COF-JNU of the present invention, the yield rate of the catalytic reaction for the bulk ring-opening polymerization of lactide into polylactic acid is over 95%, and the range of Mn is 1×10 4 to 5×10 4 , PDI is 1.10 ~ 1.30.
进一步地,所述的一种由双胍构建而成的共价有机框架材料COF-JNU,在催化乳酸直接缩聚合成聚乳酸以及丙交酯本体开环聚合成聚乳酸后,反应液通过简单处理后过滤即可回收该催化剂,在洗涤干燥之后,即可用于下一轮非均相催化反应。Further, the described covalent organic framework material COF-JNU constructed from biguanides, after catalyzing the direct polycondensation of lactic acid into polylactic acid and the bulk ring-opening polymerization of lactide into polylactic acid, the reaction solution is simply treated. The catalyst can be recovered by filtration, and after washing and drying, it can be used for the next round of heterogeneous catalytic reaction.
本发明相较于现有技术的优势和有益效果在于:Compared with the prior art, the present invention has the following advantages and beneficial effects:
(1)本发明的双胍基共价有机框架材料COF-JNU具有较好的热稳定性、催化活性、以及循环再使用性能;(1) The biguanide-based covalent organic framework material COF-JNU of the present invention has better thermal stability, catalytic activity, and recycling performance;
(2)本发明的双胍基共价有机框架材料COF-JNU可在多种单一或混合溶剂条件下制备,合成方法具有普适性,合成方法简单,结构可控;(2) The biguanide-based covalent organic framework material COF-JNU of the present invention can be prepared under a variety of single or mixed solvent conditions, the synthesis method is universal, the synthesis method is simple, and the structure is controllable;
(3)本发明的双胍基共价有机框架材料COF-JNU在催化乳酸直接缩聚合成聚乳酸以及丙交酯本体开环聚合成聚乳酸的应用中具有较高的催化效率,且聚合物聚合度可以根据需求受控合成,分子量分布指数PDI窄;(3) The biguanide-based covalent organic framework material COF-JNU of the present invention has high catalytic efficiency in the application of catalyzing the direct polycondensation of lactic acid into polylactic acid and the bulk ring-opening polymerization of lactide into polylactic acid, and the degree of polymer polymerization It can be synthesized in a controlled manner according to demand, and the molecular weight distribution index PDI is narrow;
(4)本发明的双胍基共价有机框架材料COF-JNU在催化乳酸直接缩聚合成聚乳酸以及丙交酯本体开环聚合成聚乳酸的应用中催化剂与产物易于分离,且产物中无催化剂残留,合成的聚乳酸具有高度生物安全性。(4) The biguanide-based covalent organic framework material COF-JNU of the present invention is easy to separate the catalyst and the product in the application of catalyzing the direct polycondensation of lactic acid into polylactic acid and the bulk ring-opening polymerization of lactide into polylactic acid, and there is no catalyst residue in the product , the synthetic polylactic acid is highly biosafe.
附图说明Description of drawings
图1为本发明实施例1的COF-JNU-01的红外光谱图;Fig. 1 is the infrared spectrogram of COF-JNU-01 of the embodiment of the
图2为本发明实施例1的200nm标尺的COF-JNU-01的透射电镜图;Fig. 2 is the transmission electron microscope picture of COF-JNU-01 of the 200nm scale of the embodiment of the
图3为本发明实施例1的500nm标尺的COF-JNU-01的透射电镜图;Fig. 3 is the transmission electron microscope picture of COF-JNU-01 of the 500nm scale of Example 1 of the present invention;
图4为本发明实施例1的COF-JNU-01的热重分析图;Fig. 4 is the thermogravimetric analysis diagram of COF-JNU-01 of the embodiment of the
图5为本发明实施例1的COF-JNU-01的氮气吸附-脱附曲线图。5 is a nitrogen adsorption-desorption curve diagram of COF-JNU-01 of Example 1 of the present invention.
具体实施方式Detailed ways
以下结合附图和优选实施例对本发明作进一步说明,本实施例在以本发明技术方案为前提下进行实施,给出了详细的实施方式和过程,但本发明的保护范围不限于下述的实施例,下列实施例中未注明具体条件的实验方法,通常按照常规条件,或按制造厂商所建议的条件。The present invention will be further described below with reference to the accompanying drawings and preferred embodiments. This embodiment is implemented on the premise of the technical solution of the present invention, and provides detailed implementation methods and processes, but the protection scope of the present invention is not limited to the following Examples, the experimental methods without specific conditions in the following examples are usually based on conventional conditions or conditions suggested by the manufacturer.
本发明实施例和对比例所用试剂如下表1所示,但不以此为限:The reagents used in the examples of the present invention and the comparative examples are shown in Table 1 below, but are not limited thereto:
表1Table 1
实施例1Example 1
一种双胍基共价有机框架材料(COF-JNU-01)的制备方法,包括如下步骤:A preparation method of a biguanide-based covalent organic framework material (COF-JNU-01), comprising the following steps:
称取三聚氰胺(0.42g,0.33mmol)、二氰胺钠(0.045g,0.5mmol)与20mL水加入至史莱克管中,搅拌时滴加HCl水溶液(0.08mL),滴加完毕后氮气保护下100℃反应36h。反应结束后静置过夜,离心后分别用乙醇和水洗三次。真空干燥后可得黄色粉末,即为共价有机框架材料COF-JNU-01。Weigh melamine (0.42g, 0.33mmol), sodium dicyanamide (0.045g, 0.5mmol) and 20mL of water into the Shrek tube, add HCl aqueous solution (0.08mL) dropwise while stirring, and under nitrogen protection after the
本发明对上述合成的双胍基共价有机框架材料COF-JNU-01进行了表征。The present invention characterizes the above-synthesized biguanide-based covalent organic framework material COF-JNU-01.
其中,图1所示为COF-JNU-01的红外光谱图,表明了COF-JNU-01的成功合成。Among them, Figure 1 shows the infrared spectrum of COF-JNU-01, indicating the successful synthesis of COF-JNU-01.
图2和图3分别为200nm、500nm标尺的COF-JNU-01的透射电镜图,表明COF-JNU-01呈薄片状,为微米级有机框架材料,形成较大的比表面积,有利于提高催化反应活性。Figures 2 and 3 are the TEM images of COF-JNU-01 with 200nm and 500nm scales, respectively, showing that COF-JNU-01 is flake-like and is a micron-scale organic framework material, forming a large specific surface area, which is conducive to improving the catalysis reactivity.
图4为COF-JNU-01的热重分析图,显示了COF-JNU-01较好的热稳定性,从而确保了本发明的非均相催化剂在应用过程具备良好的稳定性。Figure 4 is a thermogravimetric analysis diagram of COF-JNU-01, which shows that COF-JNU-01 has better thermal stability, thereby ensuring that the heterogeneous catalyst of the present invention has good stability in the application process.
图5为COF-JNU-01的氮气吸附-脱附曲线图,表明了COF-JNU-01具有较高的比表面积。Figure 5 is the nitrogen adsorption-desorption curve of COF-JNU-01, which shows that COF-JNU-01 has a higher specific surface area.
实施例2Example 2
一种双胍基共价有机框架材料(COF-JNU-02)的制备方法,包括如下步骤:A preparation method of a biguanide-based covalent organic framework material (COF-JNU-02), comprising the following steps:
(1)单体1,4-苯二氰基胍的合成(1) Synthesis of
称取对苯二胺(1.30g,12mmol)加入二氰胺钠(0.49g,5.5mmol)的沸水溶液中,搅拌10分钟后加入1M HCl水溶液(25mL),回流3小时。反应完毕后旋去溶剂,残余物用热乙醇处理,趁热过滤得到淡灰色固体,即为单体1,4-苯二氰基胍。P-phenylenediamine (1.30 g, 12 mmol) was weighed into a boiling aqueous solution of sodium dicyanamide (0.49 g, 5.5 mmol), stirred for 10 minutes, and then added with 1 M HCl aqueous solution (25 mL), and refluxed for 3 hours. After the reaction is completed, the solvent is spun off, the residue is treated with hot ethanol, and filtered while hot to obtain a light gray solid, which is the
(2)单体1,3,5-三(4-氨基苯基)苯的合成(2) Synthesis of
称取4-氨基苯乙酮(2.7g,20mmol)加入反应瓶中,升温至130℃后逐渐融化,分批加入TsOH·H2O(0.54g,0.15eq),再升温至145℃反应16h。反应结束后加入乙酸乙酯使反应物溶解,再加入水萃取。有机相中加入无水硫酸钠干燥,柱层析后可得黄色粉末,即为单体1,3,5-三(4-氨基苯基)苯。4-Aminoacetophenone (2.7g, 20mmol) was weighed into the reaction flask, heated to 130°C and then gradually melted, TsOH·H 2 O (0.54g, 0.15eq) was added in batches, and then the temperature was raised to 145°C and reacted for 16h . After the reaction, ethyl acetate was added to dissolve the reactant, and then water was added for extraction. Anhydrous sodium sulfate is added to the organic phase to dry, and a yellow powder can be obtained after column chromatography, which is the
(3)共价有机框架材料COF-JNU-02的合成(3) Synthesis of covalent organic framework material COF-JNU-02
称取单体1,3,5-三(4-氨基苯基)苯(0.117g,0.33mol)、1,4-苯二氰基胍(0.121g,0.5mmol)、与20mL水加入至史莱克管中,搅拌时滴加HCl水溶液(0.08mL),滴加完毕后氮气保护下100℃反应36h。反应结束后静置过夜,离心后分别用乙醇和水洗三次。真空干燥后可得黄色粉末,即为共价有机框架材料COF-JNU-02。Weigh the
实施例3Example 3
一种双胍基共价有机框架材料(COF-JNU-03)的制备方法,包括如下步骤:A preparation method of a biguanide-based covalent organic framework material (COF-JNU-03), comprising the following steps:
(1)单体2,4,6-三(4-氨基苯基)-1,3,5-三嗪的合成(1) Synthesis of monomer 2,4,6-tris(4-aminophenyl)-1,3,5-triazine
称取4-氨基苯腈(3.08g,26mmol)加入反应瓶中,再加入20mL氯仿作溶剂,在冰浴下非常缓慢地滴加三氟甲烷磺酸(8mL,88.8mmol),滴加时反应液变粘稠,滴加完毕后氮气保护。搅拌1h后移至室温后搅拌24h。反应结束后量取40mL蒸馏水加入反应液中,再缓慢加入2M NaOH溶液中调节滤液pH至中性,反应液由粘稠变为有黄色固体析出,抽滤可得粗产物。粗产物通过蒸馏水洗涤五次,柱层析得淡黄色粉末,即为单体2,4,6-三(4-氨基苯基)-1,3,5-三嗪。Weigh 4-aminobenzonitrile (3.08g, 26mmol) into the reaction flask, then add 20mL of chloroform as a solvent, very slowly add trifluoromethanesulfonic acid (8mL, 88.8mmol) dropwise in an ice bath, and react during dropwise addition The liquid became viscous, nitrogen protection was completed after the dropwise addition. After stirring for 1 h, the mixture was moved to room temperature and stirred for 24 h. After the reaction, 40 mL of distilled water was weighed and added to the reaction solution, and then 2M NaOH solution was slowly added to adjust the pH of the filtrate to neutral. The crude product was washed five times with distilled water, and a pale yellow powder was obtained by column chromatography, which was the monomer 2,4,6-tris(4-aminophenyl)-1,3,5-triazine.
(2)共价有机框架材料COF-JNU-03的合成(2) Synthesis of covalent organic framework material COF-JNU-03
称取2,4,6-三(4-氨基苯基)-1,3,5-三嗪(0.118g,0.33mmol)、二氰胺钠(0.045g,0,5mmol)与20mL水加入至史莱克管中,搅拌时滴加HCl水溶液(0.08mL),滴加完毕后氮气保护下100℃反应36h。反应结束后静置过夜,离心后分别用乙醇和水洗三次。真空干燥后可得黄色粉末,即为共价有机框架材料COF-JNU-03。Weigh 2,4,6-tris(4-aminophenyl)-1,3,5-triazine (0.118g, 0.33mmol), sodium dicyanamide (0.045g, 0,5mmol) and 20mL of water into In the Shrek tube, HCl aqueous solution (0.08 mL) was added dropwise while stirring, and after the dropwise addition was completed, the reaction was carried out at 100° C. for 36 h under nitrogen protection. After the reaction, it was left to stand overnight, and after centrifugation, it was washed three times with ethanol and water, respectively. After vacuum drying, a yellow powder can be obtained, which is the covalent organic framework material COF-JNU-03.
实施例4Example 4
一种双胍基共价有机框架材料COF-JNU-04的制备方法,包括如下步骤:A preparation method of biguanide-based covalent organic framework material COF-JNU-04, comprising the following steps:
称取1,3,5-三氨基苯(0.41g,0.33mmol)、1,4-苯二氰基胍(0.121g,0.5mmol(制备方法同实施例2的步骤(1))与20mL水加入至史莱克管中,搅拌时滴加HCl水溶液(0.08mL),滴加完毕后氮气保护下100℃反应36h。反应结束后静置过夜,离心后分别用乙醇和水洗三次。真空干燥后可得黄色粉末,即为共价有机框架材料COF-JNU-04。
实施例2~4所获得的产物同实施例1的方法进行红外光谱、透射电镜、热重分析及氮气吸附-脱附的测定,获得了与实施例1近似的技术效果,也都具备良好的分散性、较高的比表面积以及优异的热稳定性。The products obtained in Examples 2 to 4 were measured by infrared spectroscopy, transmission electron microscopy, thermogravimetric analysis and nitrogen adsorption-desorption with the method of Example 1, and obtained technical effects similar to those in Example 1, and all had good performance. Dispersibility, high specific surface area and excellent thermal stability.
实施例5Example 5
本发明的双胍基共价有机框架材料COF-JNU在催化乳酸直接缩聚合成聚乳酸应用中表现出优异的催化活性及其便于分离回收性能。现以实施例1所合成的双胍基共价有机框架材料COF-JNU-01在催化乳酸直接缩聚合成聚乳酸反应中的应用情况如下说明。The biguanide-based covalent organic framework material COF-JNU of the present invention exhibits excellent catalytic activity in the application of catalyzing the direct polycondensation of lactic acid into polylactic acid and its convenient separation and recovery performance. The application of the biguanide-based covalent organic framework material COF-JNU-01 synthesized in Example 1 in the reaction of catalyzing the direct polycondensation of lactic acid into polylactic acid is described as follows.
(1)寡聚乳酸OLLA的合成(1) Synthesis of oligomeric lactic acid OLLA
称取L-乳酸(2g)和COF-JNU-01(0.1g),在氮气保护下置于30torr的密封反应釜,135℃下反应2h,后可得到寡聚乳酸OLLA的粘稠液体混合物。Weigh L-lactic acid (2g) and COF-JNU-01 (0.1g), place them in a sealed reactor of 30torr under nitrogen protection, and react at 135°C for 2h, and then a viscous liquid mixture of oligomeric lactic acid OLLA can be obtained.
(2)聚乳酸PLLA的合成(2) Synthesis of polylactic acid PLLA
将步骤(1)得到的寡聚乳酸OLLA的粘稠液体混合物继续加热至175℃,同时逐渐将反应釜中压力降至10torr,反应2h,反应结束后冷却至室温。将反应液溶解于丙酮中,过滤回收滤饼中的催化剂COF-JNU-01进行下一次循环催化,并将滤液倒入水中,静置后离心分离沉淀物,室温真空干燥36小时,可得白色固体,即为聚乳酸PLLA,其产率为95.1%,Mn=2.1×104,PDI=1.12。The viscous liquid mixture of the oligomeric lactic acid OLLA obtained in step (1) was continued to be heated to 175° C., while the pressure in the reaction kettle was gradually reduced to 10 torr, and the reaction was performed for 2 h. After the reaction was completed, it was cooled to room temperature. The reaction solution was dissolved in acetone, and the catalyst COF-JNU-01 in the filter cake was filtered and recovered for the next cycle of catalysis, and the filtrate was poured into water. The solid, namely polylactic acid PLLA, had a yield of 95.1%, Mn=2.1×10 4 , and PDI=1.12.
实施例6Example 6
本发明的双胍基共价有机框架材料COF-JNU在催化丙交酯本体开环聚合成聚乳酸应用中表现出优异的催化活性及其便于分离回收性能。以实施例1所合成的双胍基共价有机框架材料COF-JNU-01在催化丙交酯本体开环聚合成聚乳酸反应中的应用情况如下说明。The biguanide-based covalent organic framework material COF-JNU of the present invention exhibits excellent catalytic activity in the application of catalyzing the bulk ring-opening polymerization of lactide into polylactic acid, and its convenient separation and recovery performance. The application of the biguanide-based covalent organic framework material COF-JNU-01 synthesized in Example 1 in the reaction of catalyzing the bulk ring-opening polymerization of lactide into polylactic acid is described as follows.
将单体L-丙交酯(1g)与COF-JNU-01(0.05g),氮气保护下置于反应釜中,130℃下反应3h,反应结束后冷却至室温。将反应液溶解于丙酮中,过滤回收滤饼中的催化剂COF-JNU-01进行下一次循环催化,并将滤液倒入水中,静置后离心分离沉淀物,室温真空干燥可得白色固体,即为聚乳酸PLLA,其产率为96.2%,Mn=3.2×104,PDI=1.13。The monomer L-lactide (1 g) and COF-JNU-01 (0.05 g) were placed in a reaction kettle under nitrogen protection, and reacted at 130 ° C for 3 h, and cooled to room temperature after the reaction. The reaction solution was dissolved in acetone, the catalyst COF-JNU-01 in the filter cake was filtered and recovered for the next cycle of catalysis, the filtrate was poured into water, the precipitate was centrifuged after standing, and the white solid was obtained by vacuum drying at room temperature. It is polylactic acid PLLA, its yield is 96.2%, Mn=3.2×10 4 , PDI=1.13.
对比例1Comparative Example 1
以双环胍为催化剂,参照专利公开号CN 102875779 B的发明专利“双环胍催化乳酸缩聚合成医用生物降解性聚乳酸的工艺方法”中的实施例2提供的方法制备聚乳酸PLLA,具体步骤为:Using bicyclic guanidine as a catalyst, with reference to the invention patent of Patent Publication No. CN 102875779 B, the method provided by Example 2 in the invention patent "Bicyclic guanidine catalyzed polycondensation of lactic acid into medical biodegradable polylactic acid" prepares polylactic acid PLLA, and the specific steps are:
在反应釜中装入80g的L-乳酸(质量含量90%),重复抽真空充氩气操作三次。在200torr下加热至110℃,脱水反应1h。然后将反应釜减压至100torr在130℃继续反应1h。然后将反应釜减压至30torr在150℃继续反应1h,得到寡聚乳酸OLLA。80 g of L-lactic acid (
向反应釜加入催化剂双环胍240mg,将反应釜减压至10torr,升温至190℃反应16h。停止反应后,将反应釜冷却至室温,将聚合物用丙酮溶解,然后倒入0℃的乙醇中,减压过滤,固体在50℃及真空下干燥36h,得到白色固体,即为聚乳酸PLLA,其产率为73.1%,Mn=2.3×104,PDI=1.70。240 mg of catalyst bicyclic guanidine was added to the reaction kettle, the pressure of the reaction kettle was reduced to 10 torr, and the temperature was raised to 190 °C for 16 h. After the reaction was stopped, the reaction kettle was cooled to room temperature, the polymer was dissolved in acetone, then poured into ethanol at 0°C, filtered under reduced pressure, and the solid was dried at 50°C under vacuum for 36 hours to obtain a white solid, which is polylactic acid PLLA , the yield was 73.1%, Mn=2.3×10 4 , PDI=1.70.
对比例2Comparative Example 2
以鸟嘌呤醋酸盐为催化剂,乙醇为引发剂,按照专利公开号CN 104892916 B的发明专利“有机胍-无毒醇催化丙交酯活性开环聚合受控合成聚乳酸的工艺”中的的实施例4提供的方法制备聚乳酸PLLA,具体步骤为:Taking guanine acetate as a catalyst and ethanol as an initiator, according to the invention patent "Organic Guanidine-Nontoxic Alcohol Catalyzed Active Ring-Opening Polymerization of Lactide to Synthesize Polylactic Acid" in the patent publication number CN 104892916 B. The method that embodiment 4 provides prepares polylactic acid PLLA, and the concrete steps are:
将单体LLA 100g,催化剂鸟嘌呤醋酸盐0.098g与引发剂乙醇0.230g加入聚合反应釜,通过三次“抽真空-换氮气”循环操作以驱除聚合釜中空气,待釜内压力恒定为0.6torr后密封反应釜,搅拌下于30min内升温至96℃,然后在115±1℃反应80min,得到白色固体,即为聚乳酸PLLA,其产率为83.7%,Mn=2.0×104,PDI=1.18。The monomer LLA 100g, the catalyst guanine acetate 0.098g and the initiator ethanol 0.230g were added to the polymerization reactor, and the air in the polymerization reactor was driven out by three "vacuum-exchange nitrogen" cycle operations, and the pressure in the reactor was kept constant at 0.6 After torr, the reactor was sealed, heated to 96°C in 30min under stirring, and then reacted at 115±1°C for 80min to obtain a white solid, namely polylactic acid PLLA, the yield was 83.7%, Mn=2.0×10 4 , PDI = 1.18.
通过比较对比例1与实施例5、对比例2与实施例6的方法制备的聚乳酸PLLA的产率、Mn和PDI数值可知,采用本发明的双胍基共价有机框架材料COF-JNU催化活性更优,且聚合物聚合度可以根据需求受控合成,分子量分布指数PDI更窄,此外,本发明的双胍基共价有机框架材料COF-JNU与产物易于分离,且产物中无催化剂残留,合成的聚乳酸具有高度生物安全性。By comparing the yield, Mn and PDI values of the polylactic acid PLLA prepared by the methods of Comparative Example 1 and Example 5, Comparative Example 2 and Example 6, it can be seen that the catalytic activity of the biguanide-based covalent organic framework material COF-JNU of the present invention is It is more excellent, and the polymer polymerization degree can be controlled and synthesized according to the demand, and the molecular weight distribution index PDI is narrower. In addition, the biguanide-based covalent organic framework material COF-JNU of the present invention is easy to separate from the product, and there is no catalyst residue in the product. The polylactic acid is highly biosafe.
以上所述仅为本发明的较佳实施例,但本发明的保护范围并不局限于此。凡依本发明申请专利范围未违背本发明涉及原则所做的均等变化、简化与修饰,皆应属本发明的涵盖范围。The above descriptions are only preferred embodiments of the present invention, but the protection scope of the present invention is not limited thereto. All equivalent changes, simplifications and modifications made according to the scope of the patent application of the present invention that do not violate the principles involved in the present invention shall fall within the scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011031835.5A CN112094407B (en) | 2020-09-27 | 2020-09-27 | A kind of biguanide-based covalent organic framework material and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011031835.5A CN112094407B (en) | 2020-09-27 | 2020-09-27 | A kind of biguanide-based covalent organic framework material and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112094407A true CN112094407A (en) | 2020-12-18 |
CN112094407B CN112094407B (en) | 2021-10-08 |
Family
ID=73756567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011031835.5A Active CN112094407B (en) | 2020-09-27 | 2020-09-27 | A kind of biguanide-based covalent organic framework material and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112094407B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113304261A (en) * | 2021-05-28 | 2021-08-27 | 江南大学 | Construction and application of charge reversal type intelligent light diagnosis and treatment platform |
CN113788937A (en) * | 2021-09-15 | 2021-12-14 | 青岛科技大学 | Synthetic method of crystalline porous polymer material confined catalytic lactide |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08291152A (en) * | 1995-04-24 | 1996-11-05 | Taiyo Ink Mfg Ltd | Cyanoguanidine derivative and thermosetting or photosetting-thermosetting resin composition using the same |
CN101641394A (en) * | 2007-03-12 | 2010-02-03 | 巴斯夫欧洲公司 | Process for preparing products based on cyclic organic carbonates |
CN102875779A (en) * | 2012-10-16 | 2013-01-16 | 南京大学 | Process method for synthesizing medical biodegradable polylactic acid by performing polycondensation on lactic acid through catalysis of 1,5,7-triazabicyclo[4.4.0]decane-5-ene (TBD) |
CN104892916A (en) * | 2015-06-11 | 2015-09-09 | 南京大学 | Technology for controlled synthesis of polylactic acid through lactide activity ring-opening polymerization under catalytic action of organic guanidine-nontoxic alcohol |
CN105093866A (en) * | 2014-05-16 | 2015-11-25 | 佳能株式会社 | Electrophotographic member, process cartridge, and electrophotographic apparatus |
CN107129583A (en) * | 2017-05-25 | 2017-09-05 | 西北师范大学 | The synthetic method of porous organic covalent frame material with triazine structure |
CN110121548A (en) * | 2017-01-03 | 2019-08-13 | 陈煌兴 | Branched polymeric biguanide compound and application thereof |
CN110240705A (en) * | 2019-05-10 | 2019-09-17 | 山东省分析测试中心 | A kind of preparation method and applications of richness nitrogen covalent organic framework material |
CN111333836A (en) * | 2020-03-12 | 2020-06-26 | 江苏科技大学 | Porous covalent organic polymer based on melamine, preparation method and application thereof |
-
2020
- 2020-09-27 CN CN202011031835.5A patent/CN112094407B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08291152A (en) * | 1995-04-24 | 1996-11-05 | Taiyo Ink Mfg Ltd | Cyanoguanidine derivative and thermosetting or photosetting-thermosetting resin composition using the same |
CN101641394A (en) * | 2007-03-12 | 2010-02-03 | 巴斯夫欧洲公司 | Process for preparing products based on cyclic organic carbonates |
CN102875779A (en) * | 2012-10-16 | 2013-01-16 | 南京大学 | Process method for synthesizing medical biodegradable polylactic acid by performing polycondensation on lactic acid through catalysis of 1,5,7-triazabicyclo[4.4.0]decane-5-ene (TBD) |
CN105093866A (en) * | 2014-05-16 | 2015-11-25 | 佳能株式会社 | Electrophotographic member, process cartridge, and electrophotographic apparatus |
CN104892916A (en) * | 2015-06-11 | 2015-09-09 | 南京大学 | Technology for controlled synthesis of polylactic acid through lactide activity ring-opening polymerization under catalytic action of organic guanidine-nontoxic alcohol |
CN110121548A (en) * | 2017-01-03 | 2019-08-13 | 陈煌兴 | Branched polymeric biguanide compound and application thereof |
CN107129583A (en) * | 2017-05-25 | 2017-09-05 | 西北师范大学 | The synthetic method of porous organic covalent frame material with triazine structure |
CN110240705A (en) * | 2019-05-10 | 2019-09-17 | 山东省分析测试中心 | A kind of preparation method and applications of richness nitrogen covalent organic framework material |
CN111333836A (en) * | 2020-03-12 | 2020-06-26 | 江苏科技大学 | Porous covalent organic polymer based on melamine, preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
BIN LUO ET AL.: "Design of guanidyl-functionalized magnetic covalent organic framework for highly selective capture of endogenous phosphopeptides", 《JOURNAL OF CHROMATOGRAPHY B》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113304261A (en) * | 2021-05-28 | 2021-08-27 | 江南大学 | Construction and application of charge reversal type intelligent light diagnosis and treatment platform |
CN113788937A (en) * | 2021-09-15 | 2021-12-14 | 青岛科技大学 | Synthetic method of crystalline porous polymer material confined catalytic lactide |
CN113788937B (en) * | 2021-09-15 | 2023-07-04 | 青岛科技大学 | Synthesis method of lactide catalyzed by crystalline porous polymer material in limited area |
Also Published As
Publication number | Publication date |
---|---|
CN112094407B (en) | 2021-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112094407A (en) | Biguanide group covalent organic framework material and preparation method and application thereof | |
CN114456338B (en) | Photocatalytic synthesis method of benzimidazolyl covalent organic framework material | |
CN111905828A (en) | Naphthyl ligand MOF activated carbon composite catalyst and preparation method and application thereof | |
CN107602369B (en) | Preparation method of acrylic acid or acrylic ester | |
CN114316265A (en) | A kind of polythiourea compound and its preparation method and application | |
CN106496538B (en) | Synthesis method of high molecular weight polycaprolactone | |
CN109734880B (en) | Method for catalyzing lactide polymerization by using binuclear chiral amine imine magnesium complex | |
CN109749072B (en) | Method for catalyzing the polymerization of lactide by using dinuclear amine imine magnesium complex | |
CN104327108A (en) | Preparation method of methyl aluminum complex of tetradentate nitrogen and oxygen ligand | |
CN109485840B (en) | Utilize amine imine magnesium complex to catalyze the method for lactide polymerization | |
CN111454222A (en) | Synthetic method of 2,4- (1H, 3H) -quinazoline diketone and derivative thereof | |
CN101195668A (en) | Supported main catalyst for propylene polymerization and preparation method thereof | |
CN108864166B (en) | A kind of oxazoline metal compound, its preparation method and its application as catalyst | |
CN110563941B (en) | Preparation method of medical biodegradable high polymer material polycaprolactone | |
CN116283768A (en) | Preparation method of aryl acridine compound | |
CN108239263A (en) | Utilize the method for the aluminum complex catalysis caprolactone polymerization of the aldehyde radical containing bigcatkin willow | |
CN108503801B (en) | Method for catalyzing lactide polymerization by using o-phenylenediamine-containing asymmetric aluminum complex | |
CN107383351B (en) | A method of preparing L- lactide and 6-caprolactone random copolymer | |
CN108503661B (en) | Asymmetric aluminum complex containing o-phenylenediamine group, and preparation method and application thereof | |
CN116212960B (en) | A kind of aryloxy cyclic ether skeleton metal complex catalyst and its preparation method and application | |
CN115260217B (en) | A type of bridged bisoxazoline rare earth metal catalyst, preparation method and application | |
CN114605630B (en) | Rapid synthesis method of thermoplastic polycaprolactone | |
CN102250137B (en) | 3,5-ditertbutyl salicylidene ethylenediamine iron complex, and preparation method and application thereof | |
US20250059142A1 (en) | Method of preparing covalent organic frameworks | |
CN104327261A (en) | Preparation method of polylactide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |